Abstract
Nonallergic noninfectious rhinitis is a diagnosis by exclusion, meaning that a number of poorly defined nasal conditions that have in common allergy and infection as a cause of the rhinitis have been excluded. The etiology of some subgroups of nonallergic noninfectious rhinitis, like nonallergic rhinitis with eosinophilia (NARES) and drug-induced rhinitis, are quite well defined, but in the majority of the patients, the etiology and pathophysiology are unknown. These patients are classified as idiopathic rhinitis patients. A careful determination of the intensity of the symptoms combined with modern diagnostic tools enables us to discriminate idiopathic rhinitis patients from normal controls. This review discusses the possible pathophysicologic mechanisms of nonallergic noninfectious rhinitis, with emphasis on idiopathic rhinitis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
International Rhinitis Management Working Group international consensus report on the diagnosis and management of rhinitis. Allergy 1994, 49(Suppl 19):1-34.
Dykewicz MS, Fineman S, Skoner DP, et al.: Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998, 81:478–518.
Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147-S334.
Slavin RG: Occupational rhinitis. Ann Allergy Asthma Immunol 1999, 83:597–601.
Sari-Minodier I, Charpin D, Signouret M, et al.: Prevalence of self-reported respiratory symptoms in workers exposed to isocyanates. J Occup Environ Med 1999, 41:582–588.
Leroyer C, Malo JL, Girard D, et al.: Chronic rhinitis in workers at risk of reactive airways dysfunction syndrome due to exposure to chlorine. Occup Environ Med 1999, 56(5):334–338.
Shusterman D, Balmes J: Measurement of nasal irritant sensitivity to pulsed carbon dioxide: a pilot study. Arch Environ Health 1997, 52:334–340.
Mabry RL: Rhinitis of pregnancy. South Med J 1986, 79:965–971.
Settipane RA, Lieberman P: Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001, 86:494–507.
Jacobs RL, Freedman PM, Boswell RN: Nonallergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation. J Allergy Clin Immunol 1981, 67:253–262.
Moneret-Vautrin DA, Hsieh V, Wayoff M, et al.: Nonallergic rhinitis with eosinophilia syndrome a precursor of the triad: nasal polyposis, intrinsic asthma, and intolerance to aspirin. Ann Allergy 1990, 64:513–518.
Ingels K, Durdurez JP, Cuvelier C, van Cauwenberge P: Nasal biopsy is superior to nasal smear for finding eosinophils in nonallergic rhinitis. Allergy 1997, 52:338–341.
Blom HM, Godthelp T, Fokkens WJ, et al.: The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic, noninfectious perennial rhinitis. J Allergy Clin Immunol 1997, 100:739–747.
Numata T, Konno A, Hasegawa S, et al.: Pathophysiological features of the nasal mucosa in patients with idiopathic rhinitis compared to allergic rhinitis. Int Arch Allergy Immunol 1999, 119:304–313.
Sanico A, Togias A: Noninfectious, nonallergic rhinitis (NINAR): considerations on possible mechanisms. Am J Rhinol 1998, 12:65–72. This article describes possible mechanisms of idiopatic rhinitis with special emphasis on neural mechanisms.
Blom HM, Van Rijswijk JB, Garrelds IM, et al.: Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy 1997, 27:796–801. The first and only study proving the effect of capsaicin in a double blind placebo controlled manner.
Gerth van Wijk R, Dieges PH: Nasal reactivity to histamine and methacholine: two different forms of upper airway responsiveness. Rhinology 1994, 32:119–122.
Togias A, Lykens K, Kagey-Sobotka A, et al.: Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis 1990, 141:1428–1433.
Braat JP, Mulder PG, Fokkens WJ, et al.: Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity in nonallergic noninfectious perennial rhinitis. Am J Respir Crit Care Med 1998, 157:1748–1755. Describes an objective, although a little enduring, way to prove idiopatic rhinitis.
Sanico AM, Philip G, Proud D, et al.: Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy 1998, 28:92–100.
Togias AG, Naclerio RM, Proud D, et al.: Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest 1985, 76:1375–1381.
Fokkens WJ, Holm AF, Rijntjes E, et al.: Characterization and quantification of cellular infiltrates in nasal mucosa of patients with grass pollen allergy, non-allergic patients with nasal polyps and controls. Int Arch Allergy Appl Immunol 1990, 93:66–72.
Amin K, Ludviksdottir D, Janson C, et al.: Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. Am J Respir Crit Care Med 2000, 162:2295–2301.
Svensson C, Andersson M, Greiff L, Persson CG: Nasal mucosal endorgan hyperresponsiveness. Am J Rhinol 1998, 12:37–43.
Powe DG, Huskisson RS, Carney AS, et al.: Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy 2001, 31:864–872.
Blom H, Godthelp T, Fokkens W, et al.: Mast cells, eosinphils and IgE-positive cells in the nasal mucosa of patients wiht vasomotor rhinitis. An immunohistochemical study. Eur Arch Otorhinolaryngolg 1995,252(Suppl 1):S33-S39.
Platts-Mills TA: Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol 1979, 122:2218–2225.
KleinJan A, Vinke JG, Severijnen LW, Fokkens WJ: Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000, 15:491–497.
Durham SR, Gould HJ, Thienes CP, et al.: Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997, 27:2899–2906.
Vinke JG, KleinJan A, Severijnen LW, Fokkens WJ: Passive smoking causes an ‘allergic’ cell infiltrate in the nasal mucosa of non-atopic children. Int J Pediatr Otorhinolaryngol 1999, 51:73–81.
Villar MT, Holgate ST: IgE, smoking and lung function. Clin Exp Allergy 1995, 25:206–209.
Blom HM, Severijnen LA, Van Rijswijk JB, et al.: The long-term effects of capsaicin aqueous spray on the nasal mucosa. Clin Exp Allergy 1998, 28:1351–1358.
Lundblad L, Sipila P, Farstad T, Drozdziewicz D: Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol 2001, 121:505–509.
Lieberman P: Treatment update: nonallergic rhinitis. Allergy Asthma Proc 2001, 22:199–202.
Banov CH, Lieberman P: Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol 2001, 86:28–35.
Silber G, Proud D, Warner J, et al.: In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis 1988, 137:606–612.
Philip G, Sanico AM, Togias A: Inflammatory cellular influx follows capsaicin nasal challenge. Am J Respir Crit Care Med 1996, 153:1222–1229.
Jankowski R, Philip G, Togias A, Naclerio R: Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge. Rhinology 1993, 31:97–100.
Togias A, Proud D, Kagey-Sobotka A, et al.: The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine. J Allergy Clin Immunol 1987, 79:599–604.
Cruz AA, Togias AG, Lichtenstein LM, et al.: Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis 1991, 143:761–765.
Baraniuk JN: Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. J Allergy Clin Immunol 1992, 90:1045–1050. Comprehensive review on neural influences in the nasal mucosa. Ten years old, but very relevant.
Anggard A: Basic mechanisms in autonomic nervous responses in specific and nonspecific nasal hyperreactivity. Acta Otolaryngol 1993, 113:394–396.
Sanico AM, Atsuta S, Proud D, Togias A: Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. J Allergy Clin Immunol 1997, 100:632–641.
Baraniuk JN: Neuropeptides. Am J Rhinol 1998, 12:9–16. Neuropeptides made clear.
Philip G, Baroody FM, Proud D, et al.: The human nasal response to capsaicin. J Allergy Clin Immunol 1994, 94:1035–1045.
Stjarne P, Lundblad L, Lundberg JM, Anggard A: Capsaicin and nicotine-sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol 1989, 96:693–701.
Filiaci F, Zambetti G, Ciofalo A, et al.: Local treatment of aspecific nasal hyperreactivity with capsaicin. Allergol Immunopathol (Madr) 1994, 22:264–268.
Rinder J, Stjarne P, Lundberg JM: Capsaicin de-sensitization of the human nasal mucosa reduces pain and vascular effects of lactic acid and hypertonic saline. Rhinology 1994, 32:173–178.
Braat JP, Fokkens WJ, Mulder PG, et al.: Forced expiration through the nose is a stimulus for NANIPER but not for controls. Rhinology 2000, 38:172–176.
Jaradeh SS, Smith TL, Torrico L, et al.: Autonomic nervous system evaluation of patients with vasomotor rhinitis. Laryngoscope 2000, 110:1828–1831.
Fernandes CM: Bilateral transnasal vidian neurectomy in the management of chronic rhinitis. J Laryngol Otol 1994, 108:569–573.
Malmberg H, Grahne B, Holopainen E, Binder E: Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients. Clin Otolaryngol 1983, 8:273–276.
Dockhorn R, Aaronson D, Bronsky E, et al.: Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol 1999, 82:349–359. Interesting study showing the additional effect of Ipratropium bromide on local corticosteroid spray. Does it imply that different pathofysiological mechanisms play a role at the same time?
Georgitis JW, Banov C, Boggs PB, et al.: Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. Clin Exp Allergy 1994, 24:1049–1055.
Wilde AD, Cook JA, Jones AS: The nasal response to isometric exercise in non-eosinophilic intrinsic rhinitis. Clin Otolaryngol 1996, 21:84–86. New data proving a very old and more or less discarded theory on sympathetic involvement in idiopatic rhinitis
Wilde D, Cook JA, Jones AS: The nasal response to axillary pressure in non-eosinophilic intrinsic rhinitis. Clin Otolaryngol 1997, 22(3):219–221.
Tan R, Corren J: Optimum treatment of rhinitis in the elderly. Drugs Aging 1995, 7:168–175.
Kirkegaard J, Mygind N, Molgaard F, et al.: Ordinary and high-dose ipratropium in perennial nonallergic rhinitis. J Allergy Clin Immunol 1987, 79:585–590.
Greiff L, Andersson M, Akerlund A, et al.: Microvascular exudative hyperresponsiveness in human coronavirusinduced common cold. Thorax 1994, 49:121–127.
Riccio MM, Proud D: Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes. J Allergy Clin Immunol 1996, 97:1252–1263.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fokkens, W.J. Thoughts on the pathophysiology of nonallergic rhinitis. Curr Allergy Asthma Rep 2, 203–209 (2002). https://doi.org/10.1007/s11882-002-0020-3
Issue Date:
DOI: https://doi.org/10.1007/s11882-002-0020-3